Taysha Gene Therapies
Kamran Alam is a finance executive with experience with follow-on financings and M&A, served as VP Finance at AveXis where he played a key role in the acquisition of AveXis by Novartis, most recently served as SVP Finance and Principal Financial Officer at Rocket Pharma.
This person is not in any offices